CURING HEPATITIS C WITH THE NEW DIRECT ACTING ANTIVIRALS DID NOT IMPROVE INSULIN RESISTANCE AFTER ONE YEAR.

Lohanna Strauhs-Nitsch Marcela Ferro Campiolo Daphne Benatti Gonçalves Morsoletto Alcindo Pissaia Júnior Claudia Alexandre Pontes Ivantes

Published in: Arquivos de gastroenterologia (2021)

In this study, there was no statistically significant difference between HOMA-IR results in patients before and 12 months after treatment for hepatitis C. Even though patients gained weight after the cure, this was not statistically significant after a year (P=0.131).

Keyphrases

end stage renal disease
ejection fraction
insulin resistance
chronic kidney disease
metabolic syndrome
patient reported outcomes
weight gain